Michael Oinonen

623 total citations
17 papers, 521 citations indexed

About

Michael Oinonen is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Michael Oinonen has authored 17 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in General Health Professions. Recurrent topics in Michael Oinonen's work include Antibiotic Use and Resistance (4 papers), Microscopic Colitis (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). Michael Oinonen is often cited by papers focused on Antibiotic Use and Resistance (4 papers), Microscopic Colitis (4 papers) and Clostridium difficile and Clostridium perfringens research (4 papers). Michael Oinonen collaborates with scholars based in United States and United Kingdom. Michael Oinonen's co-authors include Amy Pakyz, Ronald E. Polk, Conan MacDougall, Spencer E. Harpe, Holly E. Gurgle, Norman V. Carroll, Omar M. Ibrahim, Ron E. Polk, Mera Ababneh and Karl Matuszewski and has published in prestigious journals such as Journal of the American College of Cardiology, Antimicrobial Agents and Chemotherapy and Academic Medicine.

In The Last Decade

Michael Oinonen

17 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Oinonen United States 12 228 173 151 135 110 17 521
Gail S. Itokazu United States 10 210 0.9× 171 1.0× 82 0.5× 182 1.3× 184 1.7× 17 561
S. Diamantis France 15 160 0.7× 208 1.2× 181 1.2× 101 0.7× 61 0.6× 73 596
Ed Casabar United States 13 187 0.8× 241 1.4× 162 1.1× 150 1.1× 39 0.4× 20 584
Lesley Palmay Canada 10 360 1.6× 218 1.3× 89 0.6× 132 1.0× 137 1.2× 20 607
Roger G. Finch United Kingdom 12 177 0.8× 202 1.2× 124 0.8× 124 0.9× 133 1.2× 22 533
Michaela Steib–Bauert Germany 15 363 1.6× 209 1.2× 104 0.7× 140 1.0× 55 0.5× 21 523
Brett H. Heintz United States 14 206 0.9× 231 1.3× 168 1.1× 314 2.3× 84 0.8× 38 734
M. Cecilia Di Pentima United States 14 239 1.0× 231 1.3× 138 0.9× 137 1.0× 41 0.4× 33 641
C. Dumartin France 12 351 1.5× 145 0.8× 82 0.5× 90 0.7× 167 1.5× 33 493
Sarah J. Janelle United States 5 148 0.6× 119 0.7× 105 0.7× 91 0.7× 113 1.0× 11 364

Countries citing papers authored by Michael Oinonen

Since Specialization
Citations

This map shows the geographic impact of Michael Oinonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Oinonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Oinonen more than expected).

Fields of papers citing papers by Michael Oinonen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Oinonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Oinonen. The network helps show where Michael Oinonen may publish in the future.

Co-authorship network of co-authors of Michael Oinonen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Oinonen. A scholar is included among the top collaborators of Michael Oinonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Oinonen. Michael Oinonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Oinonen, Michael, et al.. (2022). Unite 2O2ONE—Respect, Inspire, Serve. American Journal of Medical Quality. 37(3S). S1–S129. 1 indexed citations
2.
Ababneh, Mera, Spencer E. Harpe, Michael Oinonen, & Ron E. Polk. (2012). Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial Stewardship. Infection Control and Hospital Epidemiology. 33(6). 594–601. 26 indexed citations
3.
Harpe, Spencer E., et al.. (2012). Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital‐Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(8). 744–754. 11 indexed citations
4.
Pakyz, Amy, Norman V. Carroll, Spencer E. Harpe, Michael Oinonen, & Ronald E. Polk. (2011). Economic Impact of Clostridium difficile Infection in a Multihospital Cohort of Academic Health Centers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(6). 546–551. 29 indexed citations
5.
Pakyz, Amy, Holly E. Gurgle, & Michael Oinonen. (2011). Antifungal use in hospitalized adults in U.S. academic health centers. American Journal of Health-System Pharmacy. 68(5). 415–418. 21 indexed citations
6.
Pakyz, Amy, Norman V. Carroll, Spencer E. Harpe, Michael Oinonen, & Ronald E. Polk. (2010). Increase in Use of Vancomycin for Clostridium difficile Infection in US Hospitals. Infection Control and Hospital Epidemiology. 31(8). 867–868. 7 indexed citations
7.
Pakyz, Amy, Holly E. Gurgle, Omar M. Ibrahim, Michael Oinonen, & Ronald E. Polk. (2009). Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers. Infection Control and Hospital Epidemiology. 30(6). 600–603. 47 indexed citations
8.
Harpe, Spencer E., et al.. (2009). Use of International Classification of Diseases, Ninth Revision Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection. Infection Control and Hospital Epidemiology. 30(11). 1070–1076. 46 indexed citations
9.
Pakyz, Amy, Michael Oinonen, & Ronald E. Polk. (2009). Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53(5). 1983–1986. 125 indexed citations
10.
Pakyz, Amy, Conan MacDougall, Michael Oinonen, & Ronald E. Polk. (2008). Trends in Antibacterial Use in US Academic Health Centers. Archives of Internal Medicine. 168(20). 2254–2254. 140 indexed citations
11.
Arnold, Lindsay M., Michael A. Crouch, Norman V. Carroll, & Michael Oinonen. (2006). Outcomes Associated with Vasoactive Therapy in Patients with Acute Decompensated Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(8). 1078–1085. 18 indexed citations
12.
Matuszewski, Karl, et al.. (2006). Potentially inappropriate medications in hospitalized senior patients. American Journal of Health-System Pharmacy. 63(12). 1161–1165. 21 indexed citations
13.
Marks, David S., et al.. (2004). 1040-73 Financial impact of drug-eluting stents: The US academic experience. Journal of the American College of Cardiology. 43(5). A402–A402. 1 indexed citations
14.
Korner, Eli J., et al.. (2003). The Power of Collaboration: Using Internet-Based Tools to Facilitate Networking and Benchmarking Within a Consortium of Academic Health Centers. Journal of Medical Systems. 27(1). 47–56. 11 indexed citations
15.
Oinonen, Michael, William F. Crowley, Jay Moskowitz, & Peter H. Vlasses. (2001). How Do Academic Health Centers Value and Encourage Clinical Research?. Academic Medicine. 76(7). 700–706. 11 indexed citations
16.
Oinonen, Michael, Kasem S. Akhras, Connie Chen, Karl Matuszewski, & Peter H. Vlasses. (2000). Clinical and Economic Outcomes of Coronary Angioplasty Alone or in Combination with Stents in Academic Health Centers: A Retrospective Database Analysis. Value in Health. 3(4). 253–260. 4 indexed citations
17.
Oinonen, Michael, et al.. (2000). National Data Sources on the Care and Outcomes of Patients with Community Acquired Pneumonia. Journal of Medical Systems. 24(5). 267–277. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gail S. Itokazu Breakdown of academic impact, for papers by S. Diamantis Breakdown of academic impact, for papers by Ed Casabar Breakdown of academic impact, for papers by Lesley Palmay Breakdown of academic impact, for papers by Roger G. Finch Breakdown of academic impact, for papers by Michaela Steib–Bauert Breakdown of academic impact, for papers by Brett H. Heintz Breakdown of academic impact, for papers by M. Cecilia Di Pentima Breakdown of academic impact, for papers by C. Dumartin Breakdown of academic impact, for papers by Sarah J. Janelle
Rankless by CCL
2026